Personalized immunotherapy response studied in body-on-a-chip cancer models
ScienMag,
WINSTON-SALEM, NC, JULY 19, 2021 — Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as…
WINSTON-SALEM, NC, JULY 19, 2021 — Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as…
WINSTON-SALEM, NC, JULY 19, 2021 — Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as…
Newswise — WINSTON-SALEM, NC, JULY 19, 2021 -- Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid…
Post Views: 2 WINSTON-SALEM, NC, JULY 19, 2021 — Wake Forest researchers and clinicians are using patient-specific tumor…
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently developed a process that may change the…
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently developed a process that may change the…
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently developed a process that may change the…
A patient-specific tumor 'organoid' model was developed by the scientists of Wake Forest Institute for Regenerative Medicine (WFI…
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently developed a process that may change the…
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently developed a process that may change the…
WINSTON-SALEM, N.C. - DEC. 17, 2018 - Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently…